Cervical Cancer Treatment: Avastin, Genentech drug gets FDA Approval

August 17, 2014 2:42 PM

12 0

Cervical Cancer Treatment: Avastin, Genentech drug gets FDA Approval

Drug maker Genentech has announced that it has received green signal from the U.S. Food and Drug Administration (FDA) for its drug Avastin in combination chemotherapy for treating cervical cancers.

According to a FDA release, women with recurrent, persistent or metastatic cervical cancer can be treated in a regime combining Avastin (bevacizumab) with the chemotherapy drugs paclitaxel and cisplatin or in combination with topotecan and paclitaxel.

Read more

To category page

Loading...